Health & bio

New Study Flags GLP-1 Resistance in Roughly 10% of Patients

Researchers identified a genetic variant causing GLP-1 resistance in approximately 10% of patients, offering insight into disparities in drug response.

Primary sources · 1
← View the full 2026-04-16 (Thu) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →